Roche
-
Roche launches diabetes care analysis
The analysis focuses on estimated HbA1c (eHbA1c) and Points In Range (PIR), and provides crucial insights into the advantages of…
Read More » -
Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics
The new system raises the bar for performance and usability while bridging the gap between translational research and in vitro…
Read More » -
Roche presents five-year survival outcomes for Tecentriq plus chemotherapy in extensive-stage small cell lung cancer
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with…
Read More » -
FDA approves Roche’s Lunsumio to treat people with relapsed or refractory follicular lymphoma
Lunsumio is administered as an intravenous infusion for a fixed duration, which allows for time off therapy, and can be…
Read More » -
Roche bags US FDA approval for diagnostic test to aid in identifying epithelial ovarian cancer
ENTANA FOLR1 (FOLR1-2.1) RxDx Assay is the first immunohistochemistry (IHC) companion diagnostic test Roche announced the US Food and Drug…
Read More » -
Roche introduces navify brand for digital health solutions at HLTH 2022
The navify portfolio uses digital solutions, analytics and data science to provide insights that address today’s real-world challenges in health,…
Read More » -
Roche bags US FDA clearance for cobas pure integrated solutions
cobas pure integrated solutions focuses on the automation of manual tasks, reducing the hands-on maintenance time of technicians to just five…
Read More » -
Roche bags US FDA approval for VENTANA MMR RxDx Panel
The VENTANA MMR RxDx Panel is the first immunohistochemistry (IHC) companion diagnostic test to aid in identifying patients whose solid…
Read More » -
Roche launches COVID-19 At-Home Test
The kit delivers results in 15 minutes Roche Diagnostics India has launched COVID-19 At-Home Test. The over-the-counter test is intended…
Read More »